OxyPharma AB
Box 47041, S-100 74 Stockholm, Sweden
Visiting address: Nybohovsbacken 23-25
Telephone: +46 (0)8 726 17 00
Ulf Björklund, CEO
ulf.bjorklund@oxypharma.com
Phone: +46 (0)8 726 17 02
Peter Karaszi, Press Officer
peter.karaszi@oxypharma.com
Phone: +27 21 439 8806
Mobile: +27 83 243 5797 or +46 70 341 4653
The Company's type of incorporation is regulated by the Swedish Companies Act (1975:1385). The Company was registered with the Swedish Patent and Registration Office in March 2001 with corporate identity number 556608-9958.
Box 47041, S-100 74 Stockholm, Sweden
Visiting address: Nybohovsbacken 23-25
Telephone: +46 (0)8 726 17 00
Ulf Björklund, CEO
ulf.bjorklund@oxypharma.com
Phone: +46 (0)8 726 17 02
Peter Karaszi, Press Officer
peter.karaszi@oxypharma.com
Phone: +27 21 439 8806
Mobile: +27 83 243 5797 or +46 70 341 4653
The Company's type of incorporation is regulated by the Swedish Companies Act (1975:1385). The Company was registered with the Swedish Patent and Registration Office in March 2001 with corporate identity number 556608-9958.